The widely used cough suppressant dextromethorphan is an NMDA receptor antagonist. Seyltx and Atlanta-based NeurOp are ...

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 6, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN ...

Seyltx, Inc., ("Seyltx", "Company") a clinical-stage biotherapeutics company focused on developing therapies to treat chronic cough, today announced it has entered into an option agreement with NeurOp ...

A presentation given by Mikhail Kalinichev, Head of Translational Science at Addex will describe the progress seen to date ...

US biotech Trevi Therapeutics (Nasdaq: TRVI) has raised around $115 million in a public stock offering, giving it fresh ...

Wet cough over a period lasting longer than four weeks? We are supposed to believe that this is not unusual for children, nor ...

Seyltx, Inc. a clinical-stage biotherapeutics company focused on developing innovative therapies to treat chronic cough and other neuronal hypersensitivity indications, today announced promising ...

Discover 8 key causes of bloody cough from infections to lung conditions. Learn when coughing blood needs medical attention ...

Trevi's Haduvio met its primary endpoint in a Phase 2b trial for IPF-related chronic cough, with statistically significant ...

The Centers for Disease Control and Prevention (CDC) advises looking for other symptoms associated with the NB.1.8.1 variant.

Wet cough over a period lasting longer than four weeks? We are supposed to believe that this is not unusual for children, nor ...